UNC Pleural Fluid Registry

Breast Cancer Clinical Trial

Official title:

University of North Carolina Pleural Fluid Registry

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05620329
• Other study ID #: LCCC1754
• Status: Recruiting
• Start date: January 24, 2018
• Est. completion date: January 24, 2050

Study information

• Verified date: November 2023
• Source: UNC Lineberger Comprehensive Cancer Center
• Contact: Carmmen Garcia
• Phone: +1 954-336-7499
• Email: carmmene[@]med.unc.edu
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Research with biospecimens such as blood, tissue, or body fluids can help researchers understand how the human body works. Researchers can make new tests to find diseases, understand how treatments work, or find new ways to treat a disease. The purpose of this study is to collect biospecimens for research from patients with known or suspected lung cancer. The information learned from the biospecimens may be used in future treatments. The purpose of this protocol is to create a pleural fluid registry for use in future studies.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 9999
• Est. completion date: January 24, 2050
• Est. primary completion date: January 24, 2050
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients who are 18 years or older

• Inpatients and outpatients

• Diagnosed with pleural fluid, are referred for and undergo clinically indicated drainage who have clinical evidence of:

• pulmonary infection (such as fever, leukocytosis, new or worsening infiltrate on chest x-ray, or clinical deterioration) with effusion

• malignancy

Exclusion Criteria:

• A subject will not be eligible for inclusion in this registry if, in the investigator's (or treating clinician's) opinion, the patient has any concurrent medical condition that may preclude their ability to undergo pleural fluid drainage safely.

• Incarcerated individuals

Related Conditions & MeSH terms

• Breast Cancer
• Empyema
• Lung Cancer
• Lung Infection
• Malignant Pleural Effusion
• Pleural Effusion
• Pleural Effusion, Malignant

Locations

Country	Name	City	State
United States	UNC Lingeberger Comprehensive Cancer Center	Chapel Hill	North Carolina

Sponsors (1)

Lead Sponsor	Collaborator
UNC Lineberger Comprehensive Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Creation of a pleural fluid registry	Biological specimens and corresponding clinical data from subjects will be collected during standard of care procedures and medical record abstraction to support the creation of a pleural fluid registry.	32 years

External Links

•   University of North Carolina Lineberger Comprehensive Cancer Center Clinical Trials